Tuberculosis News and Research

Latest Tuberculosis News and Research

Top scientific experts publish new TB vaccine Blueprint

21 Mar 2012

TB Alliance launches Phase II clinical trial to test new drug regimen among people with TB, MDR-TB

The TB Alliance on Monday announced it has launched a Phase II clinical trial "of a new treatment regimen for tuberculosis, including for patients with resistance to existing multi-drug programs," Agence France-Presse reports.

21 Mar 2012

Transforming biomedical research to develop TB vaccines

In the past decade, scientists have made significant progress building the critical knowledge and infrastructure needed to identify and develop novel tuberculosis (TB) vaccine candidates and move the most promising ones into human clinical trials. The results of those trials, coupled with advances from other TB studies, have paved the way for the next 10 years of research on TB vaccines, a critical component of TB control efforts, note scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

21 Mar 2012

Reuters examines global rise in drug-resistant tuberculosis cases

"[O]ften seen in the wealthy West as a disease of bygone eras," Reuters examines rising rates of tuberculosis (TB) -- drug-resistant TB in particular -- among the world's rich and poor. "[R]apidly rising rates of drug-resistant TB in some of the wealthiest cities in the world, as well as across Africa and Asia, are again making history," Reuters writes.

21 Mar 2012

Closer to effective screening for TB

An Australian scientist will bring effective screening for tuberculosis a step closer with his latest study in Vietnam- where he now lives and works.

21 Mar 2012

New vaccine strategy to advance solutions for tuberculosis

Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis , the strategic blueprint for the TB vaccine field, represents consensus reached by the TB vaccine community.

20 Mar 2012

CSIS report examines HIV prevention, care among people who inject drugs in Ukraine

A new report, titled "Injection Drug Use in Ukraine" and published by the Center for Strategic & International Studies (CSIS), examines the challenges of providing HIV prevention and care services in the country, particularly to people who inject drugs (PWID), who accounted for "nearly 50 percent of new HIV infections registered in 2010," according to the CSIS website.

20 Mar 2012

TB Alliance launches new combination drug trial

In an ambitious effort to stem the dangerous tide of tuberculosis (TB) and deadly drug-resistant TB around the world, TB Alliance today announced that it has launched a first-of-its-kind clinical trial to test a novel drug combination – in both patients who have TB and those who have multidrug-resistant TB (MDR-TB).

19 Mar 2012

Tiny Tim may have suffered from rickets and TB

Le Bonheur Professor Russell Chesney, M.D. believes he knows what was ailing Tiny Tim, the iconic character from Charles Dickens' "A Christmas Carol." Based on detailed descriptions of both the symptoms and living conditions of 18th century London, Dr. Chesney hypothesizes that Tiny Tim suffered from a combination of rickets and tuberculosis (TB).

17 Mar 2012

Cuts to health budget lead to increases in HIV/AIDS, malaria, TB incidence in Greece

"The savage cuts to Greece's health service budget have led to a sharp rise in HIV/AIDS and malaria in the beleaguered nation, said a leading aid organization on Thursday," the Guardian's "News Blog" reports.

17 Mar 2012

Gates Foundation grants biotech firm Aeras $220 million over 5 years to develop TB vaccines

The Bill & Melinda Gates Foundation is "to give $220 million over five years to the non-profit biotech firm Aeras to develop vaccines to fight tuberculosis [TB], a company statement said Thursday," Agence France-Presse reports (3/15).

17 Mar 2012

Japan makes largest-ever contribution to Global Fund

Japan on Monday provided a $340 million contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria, "the highest amount that Japan has ever made in 10 years of vigorous support for the Global Fund," according to a fund press release.

16 Mar 2012

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Abbott today announced the initiation of two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa.

16 Mar 2012

More women need regular checks for Chlamydia infection: CDC

According to new figures from the Centers for Disease Control and Prevention (CDC), not many young, sexually active women in the United States are getting screened for chlamydia.

15 Mar 2012

UMDNJ to receive TB biomarkers grant from Gates Foundation

The University of Medicine and Dentistry of New Jersey (UMDNJ) announced today that Dr. David Alland, professor of medicine, chief of infectious diseases, and director of the Center for Emerging and Re-Emerging Pathogens at UMDNJ-New Jersey Medical School, will receive a tuberculosis (TB) biomarkers grant awarded by the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world.

15 Mar 2012

Mobile phones could play a valuable role in helping HIV patients to take medication every day

Mobile phones could play a valuable role in helping HIV patients to take their medication every day, according to a new Cochrane Systematic Review. The researchers found that patients were less likely to miss doses if they were sent weekly mobile phone text message reminders.

15 Mar 2012

Largest-ever study of community-wide TB drug prevention did not improve TB control in South African mines

"After seven years of research, the world's largest study of preventative tuberculosis (TB) therapy has found that untargeted, community-wide distribution of TB prevention drugs did not improve TB control in South African gold mines," PlusNews reports.

15 Mar 2012

Narcotic drug use should be treated as illness, U.N. drug office director says

"Prevention, treatment, rehabilitation, reintegration and health have to be recognized as key elements in our strategy" to fight drug demand, supply and trafficking, U.N. Office on Drugs and Crime Executive Director Yuri Fedotov said Monday at the opening session of the U.N. Commission on Narcotic Drugs in Vienna, United Press International reports.

14 Mar 2012

Trudeau Institute creates TICRO to expand the scope of biomedical research

The Trudeau Institute announced today that it has expanded the scope of its biomedical research by creating a contract research organization (CRO), the Trudeau Institute Contract Research Organization.

13 Mar 2012

Global Fund donors 'earmark' funds for capacity-building, Fund's general manager says

Gabriel Jaramillo, the general manager of the Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria, said in an interview on Friday that "quite a few donors" to the fund "have earmarked portions of their donations to us, their contributions, to capacity-building," the Associated Press/Washington Post reports.

13 Mar 2012

Tuberculosis News and Research

Latest Tuberculosis News and Research

Top scientific experts publish new TB vaccine Blueprint

TB Alliance launches Phase II clinical trial to test new drug regimen among people with TB, MDR-TB

Transforming biomedical research to develop TB vaccines

Reuters examines global rise in drug-resistant tuberculosis cases

Closer to effective screening for TB

New vaccine strategy to advance solutions for tuberculosis

CSIS report examines HIV prevention, care among people who inject drugs in Ukraine

TB Alliance launches new combination drug trial

Tiny Tim may have suffered from rickets and TB

Cuts to health budget lead to increases in HIV/AIDS, malaria, TB incidence in Greece

Gates Foundation grants biotech firm Aeras $220 million over 5 years to develop TB vaccines

Japan makes largest-ever contribution to Global Fund

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

More women need regular checks for Chlamydia infection: CDC

UMDNJ to receive TB biomarkers grant from Gates Foundation

Mobile phones could play a valuable role in helping HIV patients to take medication every day

Largest-ever study of community-wide TB drug prevention did not improve TB control in South African mines

Narcotic drug use should be treated as illness, U.N. drug office director says

Trudeau Institute creates TICRO to expand the scope of biomedical research

Global Fund donors 'earmark' funds for capacity-building, Fund's general manager says

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Tuberculosis News and Research

Latest Tuberculosis News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in